ESC Professional Premium Access

Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation

Congress Presentation

About the speaker

Doctor Paul Guedeney

Pitie Salpetriere APHP University Hospital, Paris (France)
0 follower

5 more presentations in this session

Trends in outcomes, complications and readmission rates in patients undergoing transcatheter aortic valve implantation: a nationwide analysis from 2012 to 2019

Speaker: Doctor A. Goel (Valhalla, US)

Thumbnail

Hospital procedural volume and clinical outcomes for transcatheter aortic valve replacement - US nationwide readmission database, 2016-2019.

Speaker: Doctor O. Al-Taweel (Las Vegas, US)

Thumbnail

Prevalence and prognostic impact of cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. AMY-TAVI study.

Speaker: Doctor D. Lopez Otero (Santiago de Compostela, ES)

Thumbnail

Impact of periprocedural pulmonary hypertension on outcomes after TAVR: novel risk stratification from the OCEAN-TAVI Registry

Speaker: Doctor J. Miyamoto (Kanagawa, JP)

Thumbnail

Bioprosthetic valve fracture during valve-in-valve transcatheter aortic valve replacement: multicenter propensity matched analysis

Speaker: Doctor G. Bonnet (Paris, FR)

Thumbnail

Access the full session

Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations

Speakers: Doctor P. Guedeney, Doctor A. Goel, Doctor O. Al-Taweel, Doctor D. Lopez Otero, Doctor J. Miyamoto...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk